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Activation of the adenoviral E2 promoter is an early step in adenovirus gene expression. For members of the mast- and
aviadenoviruses, this requires induction of the cellular transcription factor E2F by virally encoded gene products such as E1A, E4orf6/7
and orf22/GAM-1. The newly recognized genus atadenovirus, of which the ovine isolate OAdV is the prototype, lacks any sequence
homology to those genes. To find a possible link between E2 promoter activation and OAdV gene expression, we utilized a screening
method to search for genes within the OAdV genome that were capable of stimulating the viral E2 promoter. One such gene, E43, was
identified within the proposed E4 region toward the right-hand end of the OAdV genome. The E43 gene product was also found to be
capable of stimulating E2F-1-dependent gene expression. A closer inspection of the E2 promoter revealed the presence of a non-
palindromic E2F binding site within the OAdV E2 promoter. Mutation of this site markedly reduced both E2F-1- and E43-dependent
promoter activation. Moreover, a direct protein–protein interaction of the E43 gene product with E2F, but not with the retinoblastoma
protein pRb, suggested a possible cooperation between these two proteins in activating the E2 promoter. The importance of the E43 gene
product for virus replication is also underlined by the finding that an OAdV recombinant with a functionally inactivated E43 gene showed
severely inhibited virus growth.
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Introduction (Benko¨ and Harrach, 1998; Dan et al., 1998; Farkas etOvine adenovirus type 7 (isolate 287, OAdV) (Boyle
et al., 1994) is the prototype of the atadenoviruses, a
genus that was formally recognized by the ICTV in
2002. The genus also includes egg drop syndrome virus,
several subtypes of bovine adenovirus (e.g. BAdV-4)
and other animal isolates including those from reptiles0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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Germany.al., 2002; Harrach and Benko¨, 1999; Harrach et al., 1997;
Thomson et al., 2002; reviewed in Both, 2001). These
viruses are distinguished from other adenovirus genera by
a distinct genome organization and by the fact that many
open reading frames show no detectable homology to
those of any other adenoviruses (Venktesh et al., 1998;
Vrati et al., 1995, 1996a,b). Because OAdV has been
successfully developed as a gene delivery vector (Hof-
mann et al., 1999; Khatri et al., 1997; Lo¨ser et al., 1999,
2000; Voeks et al., 2002; Xu et al., 1997; reviewed in
Both, 2002a; Lo¨ser et al., 2002) and all viral genes are
retained in many of these vectors, it is important to know
more about their function.
The transcription of adenoviral E2 genes, which code
for proteins required for viral DNA replication, is an
early step in the adenovirus life cycle. In mast- and
aviadenoviruses, activation of these genes involves the
D. Ku¨min et al. / Virology 318 (2004) 79–8980induction of transcription factors of the E2F family. In
particular, in certain mastadenoviruses (such as human
adenovirus type 5), products of the E1A and E4 region
are involved in activation of the E2F factors. The
E1A gene is the first gene to be expressed during an
adenovirus infection (reviewed in Shenk, 1996) and its
gene products override normal regulatory constraints at
the G1/S boundary and induce expression from several
viral promoters. One cellular target of E1A that is
involved in cell cycle control is the retinoblastoma
protein (pRb). E1A proteins bind to the hypophosphory-
lated form of pRb, resulting in the formation of a stable
complex between E1A and pRb and the release of
free, presumably transcriptionally active E2F (reviewed
in Nevins, 1995). On the other hand, the adenovirus
E4orf6/7 product binds to E2F, promotes E2F dimer
formation and directs such complexes to binding sites
within the HAdV5 E2 and cellular E2F-dependent pro-
moters where they bind with increased stability.
The induction of stabilized E2F binding correlates with
the transcriptional activation of these promoters (Hardy
and Shenk, 1989; Hardy et al., 1989; Huang and Hear-
ing, 1989; Marton et al., 1990; Neill and Nevins, 1991;
Neill et al., 1990; Obert et al., 1994; O’Connor and
Hearing, 1991; Reichel et al., 1989; Schaley et al., 2000).
Thus, E1A and E4orf6/7 utilize complementary mecha-
nisms for enhancing the expression of E2F-dependent
genes, including those involved in cell cycle progression.
E2F modulating activity was also described for the
GAM-1 and orf-22 gene products of CELO, the proto-
type of the aviadenovirus genus (Lehrmann and Cotten,
1999).
Members of the atadenovirus genus (typified by
OAdV) do not show any sequence homology to the
mast- and aviadenovirus genes whose products interfere
with the E2F pathway. Specifically, OAdV lacks a typical
E1 region. Instead, the left-hand region of the OAdV
genome codes for a structural protein (p32K) and three
open reading frames whose protein products have not
been formally identified. At the opposite end, the pro-
posed E4 region is located at the penultimate transcrip-
tion unit and appears to code for three putative proteins
whose functions are still unknown (reviewed in Both,
2001). At the extreme right end is the RH transcription
unit that codes for a family of related F-box proteins.
These have the potential to act as modulators of a
cellular pathway(s) which is as yet unidentified (Both,
2002b). We were therefore interested to determine wheth-
er OAdV protein(s) coded for by the LH, RH or E4
regions could participate in the activation of the viral E2
promoter and whether this activation might involve E2F
transcription factors of the ovine host cell. In the study
presented, we have identified one such gene, E43, the
product of which activated transcription from the E2
promoter. The E43 gene product also stimulated tran-
scription from a solely E2F-dependent promoter anddirectly interacted with E2F-1. In addition, functional
inactivation of the E43 gene in the OAdV genome
severely inhibited virus growth, underlining the impor-
tance of this gene product for virus replication.Results
Identification of an OAdV gene product that stimulates the
E2 promoter
Initially, we wished to determine whether infection
with OAdV resulted in an activation of the autologous
OAdV E2 promoter. For this purpose, the OAdV E2
promoter (nt 21,639–21,335 of the OAdV genome) was
cloned in front of the firefly luciferase reporter gene to
produce pOAdVE2-luc (Fig. 1A). This plasmid was used
to transfect CSL503 cells that are permissive for OAdV.
After 4 h, cells were infected with increasing amounts of
OAdV. At 30 h post-infection, cells were harvested and
reporter gene expression was assayed (Fig. 1B). Infection
with OAdV resulted in a significant increase (up to 4.8-
fold over non-transfected controls) in reporter gene activ-
ity. This indicated that OAdV might contain genes whose
products can activate the E2 promoter.
To test this hypothesis and to exclude that activation
of the OAdV E2 promoter was due to processes inde-
pendent of viral gene expression, we cloned several,
partially overlapping sub-regions of the OAdV genome
(Fig. 2A). These regions spanned the left- and right-hand
ends of the OAdV genome that contain genes of un-
known functions. The resulting plasmids were co-trans-
fected together with pOAdVE2-luc into CSL503 cells
(Fig. 2B). Whereas the plasmid containing the left-hand
end BamHI fragment of the OAdV genome (pOAdV-B1,
carrying p32 and the open reading frames LH1, 2 and 3)
did not activate luciferase gene expression from the E2
promoter, the right-hand end BamHI fragment (pOAdV-
B6) carrying the genes of the putative E4 and RH region
clearly activated luciferase gene expression. A similar
activation was observed with the right terminal HpaI
fragment of the viral genome (pOAdV-H8), which also
contained these regions. A refinement of this approach
showed that a plasmid containing the putative E4 region
of OAdV (pOAdV-E4), but not a plasmid carrying the
RH region (pOAdV-RH), was able to activate the pro-
moter. Thus, the gene function capable of stimulating the
OAdV E2 promoter appeared to reside within the pro-
posed E4 region of the virus.
The OAdV E4 region consists of three open reading
frames (E41, E42 and E43) all of which are expressed in
OAdV-infected permissive cells as shown by immunoflu-
orescence and Western blotting experiments using poly-
clonal rabbit sera raised against the individual E4
products (data not shown). To determine which of the
E4 proteins was responsible for activation of the E2
Fig. 1. Activation of the OAdV E2 promoter upon OAdV infection. (A) Scheme of plasmid pOAdVE2-luc containing the E2 promoter with the non-
palindromic E2F binding site. (B) Reporter plasmid pOAdVE2-luc (0.8 Ag) and transfection control plasmid pRSV-lacZ (0.2 Ag) were co-transfected into
CSL503 cells. At 4 h post-transfection, cells were infected with OAdV at the multiplicity of infection (moi) indicated. At 30 h post-infection, cells were
harvested and reporter gene activities were determined. The ratio of luciferase to lacZ gene activity is shown with reporter gene activity ratio in uninfected cells
set at 100%. Error bars indicate standard deviations from four independent experiments. n.i., non-infected cells.
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expression vector (see Materials and methods). The
resulting plasmids (pCI-E41, pCI-E42 or pCI-E43) were
co-transfected together with pOAdVE2-luc into CSL503
cells (Fig. 2C). Whereas co-expression of E41 and E42
did not increase reporter gene activity, a significant
activation of E2 promoter-dependent expression was ob-
served with the E43 plasmid (3.2-fold over control). This
clearly indicated that the OAdV E43 gene product could
activate the viral E2 promoter.
The E43 gene product activates E2F-dependent gene
expression
Activation of mastadenovirus E2 promoters (e.g. those
of HAdV2 and 5) involves induction of E2F transcrip-
tion factors following viral infection. To test whether
E2F might be involved in activating the E2 promoter
of OAdV (and probably other members of the atadeno-
virus genus that have sequence homology in this region),
we performed transfection experiments with plasmid
pE2F-luc that contained three palindromic E2F binding
sites linked to a TATA box in front of the firefly
luciferase reporter gene (Fig. 3). In this plasmid, lucifer-
ase gene expression was solely dependent on activated
cellular E2F (see below). Transfection of this plasmid
into CSL503 cells followed by infection with OAdV as
described for Fig. 1 resulted in a 6.8-fold stimulation of
luciferase activity, indicating that OAdV infection caused
an increase in transcriptionally active E2F (Fig. 3A).To determine which products might be involved in the
observed E2F activation, we co-transfected plasmids con-
taining overlapping OAdV fragments of the OAdV ge-
nome together with pE2F-luc into CSL503 cells. Co-
transfection resulted in a modest increase (1.8- to 2.4-fold
over control) in luciferase activity when plasmids were
used that contained the OAdV E4 region (pOAdV-B6,
pOAdV-H8 and pOAdV-E4), but not with the other
plasmids (pOAdV-B1, pOAdV-RH, data not shown). Co-
transfection of expression plasmids coding for an individ-
ual E4 gene together with pE2F-luc caused a strong
increase in luciferase gene expression when the E43 gene
was used (5.9-fold over control), whereas expression of
E41 or E42 had no effect on luciferase gene expression
(Fig. 3B). Since the stimulation of luciferase expression
from pE2F-luc was absolutely dependent on E2F (see
below), the E43 gene product clearly induced cellular
E2F activity.
E2F activates expression from the OAdV E2 promoter
The E2 promoter of OAdV contains a single, non-
palindromic E2F site (Fig. 1A). To test whether E2F was
involved in activation of the E2 promoter, we co-trans-
fected pOAdVE2-luc together with an expression plasmid
for human E2F-1. E2F-1 co-expression strongly stimulat-
ed the OAdV E2 promoter in a dose-dependent manner
up to 6.8-fold over control. In a positive control exper-
iment, luciferase expression from the artificial E2F-de-
pendent promoter (pE2F-luc) was 19.7-fold elevated with
Fig. 2. Stimulation of the OAdV E2 promoter activity with different portions of the OAdV genome. (A) Schematic organization of the OAdV virus genome and
regions of the OAdV genome subcloned as effector plasmids. (B) Reporter constructs (0.5 Ag) were co-transfected into CSL503 cells with transfection control
plasmid pRSV-lacZ (0.1 Ag). For co-transfection assays, 0.4 Ag of the following plasmids was additionally transfected: pOAdV-B1 (left-hand end BamHI
fragment; nt 1–4253 of the OAdV genome), pOAdV-B6 (right-hand end BamHI fragment; nt 20,862–29,574), pOAdV-H8 (right-hand end HpaI fragment; nt
23,585–29,574), pOAdV-E4 (nt 23,327–26,985) and pOAdV-RH (nt 25,965–29,574). (C) Reporter constructs (0.5 Ag) were co-transfected with transfection
control (0.1 Ag). For co-transfection assays, expression plasmids pCI-E41, pCI-E42, pCI-E43 (0.13 Ag) were additionally transfected. Reactions were
supplemented with pCI to 1 Ag total DNA. For B and C, transfection samples were analyzed for reporter gene expression at 48 h as described in Fig. 1. Error
bars indicate standard deviations from five independent experiments.
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Fig. 4. The OAdV E2 promoter is activated by E2F. Reporter plasmids
pOAdVE2-luc or pE2F-luc (0.7 Ag), respectively, were co-transfected into
CSL503 cells with increasing amounts of effector plasmid pCMV-E2F1
and transfection control plasmid pRSVlacZ (0.1 Ag). DNA present in
each reaction was equalized to 1 Ag with pBSKS. At 48 h post-
transfection, cells were harvested and reporter gene activities were
measured as in Fig. 1.
Fig. 3. Infection with OAdV or expression of E43 induces E2F-dependent
gene expression. (A) Reporter plasmid pE2F-luc (0.8 Ag) and transfection
control plasmid pRSVlacZ (0.2 Ag) were co-transfected into CSL503 cells.
At 4 h post-transfection, cells were infected with OAdV at increasing
multiplicity of infection (moi). At 30 h post-infection, cells were harvested
and reporter gene activities were determined. Error bars indicate standard
deviations from five independent experiments. n.i., non-infected. (B) pE2F-
luc (0.5 Ag) was co-transfected with transfection control (0.1 Ag). For co-
transfection assays, 0.13 Ag of the either pCI-E41, pCI-E42, pCI-E43 was
additionally transfected. Reactions were supplemented with pCI to 1 Ag
total DNA. At 48 h post-transfection, samples were analyzed for reporter
gene expression as described in Fig. 1. Error bars indicate standard
deviations from three independent experiments.
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that activation of the E2 promoter was dependent on the
integrity of the E2F site within the OAdV E2 promoter,
we mutated the binding site by site-directed mutagenesis
(Fig. 5A) producing plasmid pOAdVmE2-luc. Co-trans-
fection of this plasmid together with 100 ng of pCMV-
E2F-1 diminished the E2F-mediated activation of reporter
gene expression to 2.3-fold over control levels versus a
7.4-fold increase in the respective control experiment
with the unmutated plasmid (Fig. 5B). The residual
activation observed in the presence of E2F with the
mutated promoter is probably caused by the complex
nature of the viral E2 promoter which is not solely E2F
dependent but is also stimulated by other factors whichmight be activated by high E2F1 concentrations. In
addition to the direct E2F1 effect, the binding site
mutation also completely abolished the ability of E43
to stimulate E2 promoter activity when the E43 expres-
sion plasmid or pOAdV-B6 were used as effectors (Fig.
5C). This result indicates that E43 might perform its
effect on the E2 promoter via E2F-1. To test this, we co-
transfected the reporter plasmids pOAdVE2-luc or pE2F-
luc and the effector plasmid pCMV-E2F-1 with or with-
out the E43 expression plasmid into CSL503 cells. E2F
activation of both the OAdV E2 promoter and the
artificial E2F-dependent promoter was further increased
by a factor of approximately 2.5 following co-transfection
of pCMV-E2F1 and pCI-E43 (Fig. 6). This indicated that
the E43 gene product might enhance the action of E2F-1
on both promoters.
E43 does not bind to pRb, but associates with E2F
We next wished to gain some insight into the nature of
the possible interaction between the E43 gene product and
E2F-1. In the case of HAdV5, the products of two genes
are involved in induction of E2F activity: whereas the E1A
gene products interact with the pRb protein, E4orf6/7
directly binds to E2F-1. We therefore attempted to detect
a possible protein–protein interaction between E43 and
pRb. Using extracts from 293 cells, which stably express
the E1a gene, we successfully co-precipitated pRb with an
antibody directed against HAdV5 E1A. A similar experi-
ment was performed in which recombinant E43 protein
purified from Escherichia coli as a Strep-tag II fusion
protein was mixed with extracts from human 293 or ovine
HVO156 cells, respectively, and precipitated with Strep-
Fig. 5. Mutation of the E2F site reduces E2F dependence of the E2 promoter. (A) Scheme of reporter plasmid pOAdVmE2-luc containing the mutated E2F site.
The altered nucleotides are given in bold. (B) CSL503 cells were transfected with pOAdVE2-luc or pOAdVmE2-luc (0.7 Ag), respectively, together with the
transfection control pRSVlacZ (0.1 Ag) and pCMV-E2F1 (0.05 or 0.1 Ag). Reactions were supplemented to 1 Ag of total DNAwith pBSSK where necessary.
At 48 h post-infection, cells were analyzed for reporter gene expression as described in Fig. 1. Error bars indicate standard deviations from five independent
experiments. (C) CSL503 cells were co-transfected with pOAdVmE2-luc (0.5 Ag), the transfection control pRSVlacZ (0.1 Ag) and either 0.4 Ag pCI-E43 or
pOAdV-B6. At 48 h post-infection, cells were harvested and reporter gene activities were determined as described in Fig. 1. Error bars indicate standard
deviations from four independent experiments.
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in association with E43 from either cell extract despite
several attempts (data not shown), suggesting a lack of
direct interaction between E43 and pRb. The idea that
interaction with pRb is not a major mechanism of E43
action was also supported by preliminary findings that E43
could exert its effect on E2F-dependent expression in
human cell lines that do not express a functional pRb
protein (data not shown).
We next sought evidence for a direct interaction
between the E43 and the E2F-1 proteins. Recombinant
E43 fused to the Strep-tag II was mixed with cell extracts
from either ovine HVO156 or human HeLa cells andproteins were precipitated with Strep-Tactin sepharose. An
equivalent fusion of the E41 protein was used as a
control. In precipitates from extracts of both cell lines,
we clearly detected E2F-1 after precipitation with the E43,
but not with the E41 fusion protein (Fig. 7A), indicating
binding between E43 and E2F-1. This interaction was
specific as it depended on the presence of the E43
protein. Unfortunately, we could not precipitate E43 from
infected cells due to a lack of a suitable combination of
an E43-specific antibody and an antibody specific for the
ovine E2F-1 gene product. However, addition of in vitro
synthesized, 35S-labeled E43 to lysates from either
HVO156 or HeLa cells allowed precipitation of E43 with
Fig. 7. Detection of binding between OAdV E43 and E2F. (A) HVO156 or
HeLa cell lysates were mixed with Strep-E43 or Strep-E41 fusion proteins,
respectively, and proteins were precipitated using Strep-Tactin sepharose.
E2F-1 associated with the fusion proteins was detected by Western blotting
using a polyclonal rabbit anti-E2F-1 antibody. (B) Lysates from HVO156 or
HeLa cells were mixed with 35S-labeled E43 and proteins were precipitated
with a polyclonal rabbit anti-E2F-1 antibody. After SDS-PAGE co-
precipitated, radioactively labeled proteins were detected by autoradiog-
raphy. Molecular size markers are shown on the left while specific bands
are indicated on the right.
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protein which cross-reacted with the ovine protein (Fig.
7B). Precipitation was not observed with a pre-immune
serum or when using radiolabeled E41 protein instead of
E43 (data not shown). Taken together, our data suggest
that OAdV E43 probably does not bind to pRb but can
bind directly to E2F-1.
Mutation of the OAdV E43 gene severely affects virus
growth
If E43 interacts directly with E2F-1 and other family
members, the gene may be important for modulating the
cell cycle to establish optimal conditions for virus
growth. To test this, we introduced an XbaI site at
position 24,519 of the OAdV genome thereby introducing
a stop codon early in the E43 open reading frame. The
mutated OAdV genome was transfected onto the producer
cell line HVO156 and recombinant viral clones were
rescued between days 12 and 18 following transfection.
The presence of the mutation was verified by PCR
amplifying and sequencing the E4 region from three viral
clones. However, on propagation, the mutated viruses
showed severely delayed replication on both of the
currently available producer cell lines (CSL503 or
HVO156), despite several attempts. The best clone only
grew to a titer of less than 108 viral particles (vp)/ml,
whereas wild-type virus produced titers of about 1012 vp/
ml. This finding demonstrates that E43 plays an impor-
tant role in the viral life cycle and, although initiallyFig. 6. Combined effect of E2F-1 and OAdV E43 on the E2F-dependent
promoters. Reporter plasmids pOAdVE2-luc or pE2F-luc (0.5 Ag) were co-
transfected with transfection control plasmid (0.1 Ag). pCMV-E2F1 (10 ng)
and pCI-E43 (0.2 Ag) were additionally transfected either alone or in
combination. Mixtures were supplemented with background plasmids
pCMV, pCI and pGEM3 to 1 Ag total DNAwhere necessary. At 48 h post-
transfection, samples were analyzed for reporter gene expression as
described in Fig. 1. Error bars indicate standard deviations from three
independent experiments.dispensable for virus rescue, is necessary for efficient
virus multiplication.Discussion
Expression of the E2 region that encodes genes essen-
tial for viral DNA replication is an early step in the
adenovirus life cycle and requires activation of the E2
promoter(s). In some mastadenoviruses, E2 promoter acti-
vation is dependent on E2F factors that are activated by
products of the E1A and E4 regions, although not all E2F
motifs are capable of binding E2F (Schaley et al., 2000).
As OAdV shares a broad homology with other adenovi-
ruses within the E2 region (Khatri and Both, 1998; Vrati et
al., 1996a), it was expected that OAdV E2 gene expression
might also be dependent on E2F activation. However, the
OAdV E2 promoter region does not contain the inverted
E2F binding sites that are present in the E2A promoters of
mastadenoviruses such as HAdV2 and HAdV5. Instead, as
identified here, it possesses a single copy of the consensus
E2F binding sequence in close proximity to a TATA box.
The atadenovirus genus is also notable for the apparent
absence of gene homologues that could be involved in cell
cycle deregulation during infection. Specifically, there is
no E1A homologue and only minimal homology with one
(orf6) of the seven E4 genes of HAdV2 and 5 (Ta¨uber and
Dobner, 2001). Similarly, there are no apparent equivalents
of the GAM-1 or orf22 genes of the aviadenoviruses,
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capable of binding the same pRb target (Lehrmann and
Cotten, 1999).
A screen of OAdV for genes that were capable of
activating the OAdV E2 promoter identified viral protein
E43. The E43 gene product was found to induce expression
from the OAdV E2 promoter as well as from an artificial
E2F-dependent promoter. So far no evidence has been found
that E43 interacts directly with pRb to release E2F as has
been described for E1A proteins of mastadenoviruses
(reviewed in Nevins, 1995). Therefore, E43 may be func-
tionally distinct from these transforming proteins and others
such as SV40 large T antigen or papillomavirus E7 that bind
directly to pRb and related proteins. This concept is also
supported by the observation that, in contrast to HAdV5,
OAdV showed no transforming activity in a standard
transformation assay involving rodent cells (Xu et al.,
2000). Instead, we found that E43 binds directly to E2F-1,
as has also been found for the HAd5 E4orf6/7 protein
(Hardy and Shenk, 1989; Hardy et al., 1989; Huang and
Hearing, 1989; Marton et al., 1990). It is also notable that
E43 is so far the only atadenovirus gene product that has
been shown to interact with a host cell protein.
The underlying mechanism of E2F-dependent promoter
activation by E43 is not clear. E4orf6/7 has been shown to
direct E2F dimerization that is critical for activation of
cellular E2F-dependent promoters (Obert et al., 1994).
Whether E43 acts in this way is presently unknown. The
sequences involved in E4orf6/7 interaction with E2F-1 and
the binding site on E2F-1 have been identified (reviewed
in Ta¨uber and Dobner, 2001). However, there is no
detectable homology between E4orf6/7 and E43. The only
motif within the E43 protein with homology to a known
protein is a cysteine-rich motif (CCR) that is also present
in E42 and all mastadenoviral E4orf6 proteins (Nevels et
al., 2000; Vrati et al., 1996b). Cellular proteins that also
contain this motif are known to interact with E2 ligases of
the ubiquitin-dependent proteolytic system (Lorick et al.,
1999). However, at this stage, it is not clear if this motif is
of any importance to the function of E43 in stimulating
E2F-dependent gene expression and in the potential func-
tional homologue, E4orf6/7, this motif is removed by
splicing.
It is important to note that our approach did not identify
an E2 promoter-activating gene nor any E2F inducing
activity within the left-hand region of the OAdV genome
where initially, a functional homologue of E1A was
expected to reside. This again emphasizes the fundamental
differences between mast- and atadenoviruses. Similarly, a
screen of the CELO genome, an aviadenovirus, identified
Orf 22 and GAM-1 as two genes within the right-hand
quarter of the genome whose products were capable of pRb
binding and thus, E2F activation (Lehrmann and Cotten,
1999). It is therefore apparent that adenovirus genera have
evolved multiple strategies to activate E2F transcription
factors to initiate viral gene expression and replication. Itremains to be determined whether other atadenovirus genes
are also involved.
It has been shown by phylogenetic analysis of DNA
polymerase genes that adenoviruses, as typified by OAdV,
are older than viruses in other adenovirus genera and closely
related to reptilian adenoviruses (Benko¨ et al., 2002).
Therefore, E43 may represent an early version of viral
proteins with capacity to interfere with the E2F pathway.
Other adenoviruses might have acquired different, addition-
al and/or partially redundant functions for E2F deregulation
over time. Although they lack obvious homologues, it will
be interesting to determine whether other phylogenetically
older adenoviruses such as members of the siadenovirus and
the proposed ichtadenovirus genera also contain gene prod-
ucts capable of E2F interactions.Materials and methods
Cells and viruses
CSL503 (fetal ovine lung) (Pye, 1989) and HVO156
(fetal ovine skin) (Lo¨ser et al., 2002) cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen, Karlsruhe, Germany) plus 15% fetal calf serum (FCS,
BioWest, Nuaille´, France). Both cell lines are permissive for
OAdV replication. HeLa cells (ATCC CCL-2) were grown
in DMEM and 10% FCS. Media were generally supple-
mented with 2 mM glutamine, 100 Ag/ml streptomycin and
100 units/ml penicillin.
Wild-type OAdV was propagated as described (Lo¨ser et
al., 2001). The number of viral particles (vp/ml) was
determined according to the method of Maizel et al.
(1968) by measuring the absorption at 260 nm. The number
of infectious particles (ip/ml) was assayed by limiting
dilution on CSL503 cells as described elsewhere (Cichon
et al., 1999). The vp/ip ratios were generally < 20.
Infection of cells with OAdV was performed in six-well
plates at the multiplicity indicated in the Results section and
following the method described elsewhere (Ku¨min et al.,
2002).
Transfections and luciferase assays
Transfections of CSL503 cells were carried out using the
Lipofectamine Plusk kit (Invitrogen) according to the
manufacturer’s instructions. Cells were seeded 1 day before
transfection in six-well plates at a density of 3  105 per
well. Total plasmid DNA (1 Ag) in serum-free medium was
used. To normalize transfection data, pRSVlacZ (0.1 Ag)
was used for co-transfection in each experiment, and lucif-
erase and lacZ gene activities were determined in the same
cell lysate.
Luciferase assays were performed following the meth-
od described (Lo¨ser et al., 1996). Briefly, 24–48 h post-
transfection/infection, cells were washed once in PBS and
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phate (pH 7.8), 1 mM DTT, 1% Triton X-100] for 5 min.
The lysate was centrifuged to remove cell debris and a
portion of the supernatant (50 Al) was added to reaction
buffer (180 Al) [25 mM KiPO4 (pH 7.8), 4 mM EGTA,
15 mM MgSO4, 1 mM ATP, 1 mM DTT]. Luciferase
activity was measured in a LB9507 luminometer (Bert-
hold, Bad Wildbad, Germany) in the presence of 18 AM
luciferin (Sigma, Taufkirchen, Germany) for 10 s. Results
were normalized to the lacZ gene activity in the same cell
lysate.
The quantification of the lacZ gene activity was also
performed with a luminometer using the Galakto-Lightk
kit (Tropix, Bedford, USA) according to the manufactur-
er’s instructions.
Plasmids
Plasmid pE2F-luc which is based on pGL2-Basic (Prom-
ega, Mannheim, Germany) and carries three E2F con-
sensus binding sites (CGC CGC) was kindly provided by
Christian Hagemeier (Berlin, Germany). pCMV-E2F1 was
kindly provided by Kristian Helin (Helin et al., 1993). The
OAdV E2 promoter was amplified by PCR using primers
5VGCAACTGCAGAAGAAACTGTTCCAGTATC 3V and
5VGCGGGATCCGCCAGTTGTTGATGTTAACC 3V and
cloned upstream of a luciferase reporter gene in pGL2-
Basic, giving rise to pOAdVE2-luc. Plasmid pRSV-lacZ
contains the E. coli lacZ gene flanked by the RSV LTR
and the bovine growth hormone polyA-signal. The left-
hand BamHI fragment (nucleotides 1–4253) of OAdV
was cloned as an Asp718/BamHI fragment from pOAV3-
cos (Lo¨ser et al., in press) into pBSKS (Stratagene,
Heidelberg, Germany) giving rise to pOAdV-B1. pOAdV-
B6 contains the right-hand end BamHI fragment (nucleo-
tides 20,862–29,574 of the OAdV genome) and was
cloned as a BamHI/Asp718 fragment into pBSKS, while
pOAdV-H8 contains the right-hand end HpaI fragment
(nucleotides 23,585–29,574 of the OAdV genome)
cloned as HpaI/Asp718 into the same vector. pOAdV-E4
(nucleotides 23,327–26,985) was obtained by PstI/HindIII
digest of pOAdV-B6 and subsequent insertion into
pBSKS (Stratagene), while pOAdV-RH (nucleotides
25,965–29,574) was generated by cutting pOAdV-H8
with SpeI and ligation of the cleavage product into
pBSKS. E41, E42 and E43 from OAdV were PCR-
cloned without introns into pCI (Promega) using primers
5VCGGGGTACCATGAATCAACATGGGAGAAT 3V and
5 VCGGGGTACCTCACTGCCAATCAGGCTT 3 V,
5VCGGGGTACCATGGATAAGCAAATCAAAGTT 3V
and 5VCGGGGTACCGAGTTCATGCTACATCCAA 3V, or
5VCGGGGTACCATGAACTCCATTATGTGTTG 3V and
5VCGGGGTACCTTAGCTGAAAATGTACCAGT 3V, re-
spectively.
For expression of E41 and E43 in E. coli, both genes
were PCR amplified using primers 5 VGGAATTCCCAATCAACATGGGAGAATGCT 3V and 5VCAAC
TGCAGTCACTGCCAATCAGGCTTAA 3 V, o r
5VGGAATTCCAACTCCATTATGTGTTGCGA 3V and
5VCAACTGCAGTTAGCTGAAAATGTACCAGT 3V, re-
spectively, and cloned into pASK-IBA5 (IBA GmbH,
Go¨ttingen, Germany) to give rise to pIBA5-E41 and
pIBA5-E43. pGEM3-E43 and pGEM3-E41 for in vitro
transcription/translation were cloned by excising the gene
from pCI-E43 with EcoRI and BamHI and inserting it into
pGEM3 (Promega).
Mutation of E2F binding site in the OAdV E2 promoter
reporter gene construct
Using primers 5VCTGGTTGAGCCATGGATCGAAA
ATTTAAAACTATAAAGCCTCAGC 3 V and 5 VGC
TGAGGCTTTATAGTTTTAAATTTTCGATCCATG
GCTCAACCAG 3V(mutated nucleotides are shown in
bold), the putative E2F binding site in the E2 promoter
was mutated in pOAdVE2-luc using the QuickChangeTM
site-directed mutagenesis kit (Stratagene).
Mutation of the E43 ORF of OAdV and rescue of mutated
virus
A stop codon was introduced immediately down-
stream of the start codon of E43 by prior sub-cloning
of the E4 region as an AflII fragment. Following this,
an AccI/HpaI segment within the OAdV AflII fragment
was further sub-cloned into pBSSK. Using primer pair
5VGATTCATCATCTTTTTTATTTCTAGAGTGATATACC
GTTTGTTAG 3Vand 5VCTAACAAACGGTATATCAC
TCTAGAAATAAAAAAGATGATGAATC 3V (mutated
nucleotides shown in bold) and the QuickChangek site-
directed mutagenesis kit (Stratagene), a XbaI site was
introduced at position 24,519 of the OAdV genome to
produce a stop codon after amino acid 15 of the E43 open
reading frame. The mutated fragment was then re-intro-
duced into the original plasmid and virus was rescued as
described (Lo¨ser et al., 2001).
Production of recombinant proteins in E. coli
E41 and E43 were expressed in E. coli BL-21 (Strata-
gene) from pIBA5-E41 and pIBA5-E43, respectively, using
the Strep-tag kit (IBA) according to the manufacturer’s
instructions.
Immunoprecipitations of proteins
Cells were seeded in 6-cm dishes and harvested
when approximately 90% confluent utilizing solutions pro-
vided in the Protein A immunoprecipitation kit (Roche,
Mannheim, Germany) according to the manufacturer’s
instructions. Proteins were recovered with either 1 Ag specific
antibody and protein A agarose or in association with 20 Ag
D. Ku¨min et al. / Virology 318 (2004) 79–8988Strep-tagged protein purified from E. coli and Strep-Tactin
sepharose (IBA) and analyzed by Western blotting. E1A and
polyclonal rabbit anti-E2F-1 antibodies were obtained from
Santa Cruz (Heidelberg, Germany). A mouse monoclonal
antibody directed against human pRb was obtained from
Pharmingen (Heidelberg, Germany).
E43 was synthesized from the pGEM3 plasmids and
labeled with 35S-methionine (Amersham, Freiburg, Ger-
many) using the TnTR Coupled Wheat Germ Extract
System (Promega) according to the manufacturer’s instruc-
tions. Five microliter-samples were separated on 4–12%
Bis–Tris gels (Invitrogen) to confirm correct synthesis of
the proteins. Gels were then fixed in 50% (v/v) methanol,
10% (v/v) glacial acetic acid for 30 min and soaked in
Amplify (Amersham) for 15 min, dried and exposed on
Kodak BioMax MR films overnight. Radiolabeled E43 was
mixed with cell lysates and precipitated with E2F utilizing
the Protein A immunoprecipitation kit. Proteins were re-
leased by boiling the beads in 2 Laemmli sample buffer
for 5 min, separated by SDS-PAGE and visualized by
autoradiography.Acknowledgments
We thank Ulrike Schneeweiß and Sabine Wilhelm for
excellent technical support and Volker Sandig and Christian
Hagemeier for critical discussion.References
Benko¨, M., Harrach, B., 1998. A proposal for a new (third) genus within
the family Adenoviridae. Arch. Virol. 143, 829–837.
Benko¨, M., Elo, P., Ursu, K., Ahne, W., LaPatra, S.E., Thomson, D.,
Harrach, B., 2002. First molecular evidence for the existence of distinct
fish and snake adenoviruses. J. Virol. 76, 10056–10059.
Both, G., 2001. Atadenoviruses. In: Tidona, C., Darai, G. (Eds.), The
Springer Index of Viruses. Springer-Verlag, Berlin, pp. 11–17.
Both, G., 2002a. Xenogenic adenoviruses. In: Curiel, D., Douglas, J.
(Eds.), Adenoviral Vectors for Gene Therapy. Academic Press, San
Diego, pp. 447–479.
Both, G., 2002b. Identification of a unique family of F-box proteins in
atadenoviruses. Virology 304, 425–433.
Boyle, D.B., Pye, A.D., Kocherhans, R., Adair, B.M., Vrati, S., Both,
G.W., 1994. Characterisation of Australian ovine adenovirus isolates.
Vet. Microbiol. 41, 281–291.
Cichon, G., Schmidt, H.H., Benhidjeb, T., Lo¨ser, P., Ziemer, S., Haas, R.,
Grewe, N., Schnieders, F., Heeren, J., Manns, M.P., Schlag, P.M.,
Strauss, M., 1999. Intravenous administration of recombinant adenovi-
ruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.
J. Gene Med. 1, 360–371.
Dan, A., Ruzsics, Z., Russell, W.C., Benko, M., Harrach, B., 1998. Anal-
ysis of the hexon gene sequence of bovine adenovirus type 4 provides
further support for a new adenovirus genus (Atadenovirus). J. Gen.
Virol. 79, 1453–1460.
Farkas, S.L., Benko¨, M., Elo, P., Ursu, K., Dan, A., Ahne, W., Harrach, B.,
2002. Genomic and phylogenetic analyses of an adenovirus isolated from
a corn snake (Elaphe guttata) imply a common origin with members of
the proposed new genus Atadenovirus. J. Gen. Virol. 83, 2403–2410.
Hardy, S., Shenk, T., 1989. E2F from adenovirus-infected cells binds co-operatively to DNA containing two properly oriented and spaced rec-
ognition sites. Mol. Cell. Biol. 9, 4495–4506.
Hardy, S., Engel, D.A., Shenk, T., 1989. An adenovirus early region 4 gene
product is required for induction of the infection-specific form of cel-
lular E2F activity. Genes Dev. 3, 1062–1074.
Harrach, B., Benko¨, M., 1999. Phylogenetic analysis of adenovirus sequen-
ces—Proof of the necessity of establishing a third genus in the Adeno-
viridae family. In: Wold, W.S.M. (Ed.), Adenovirus Methods and
Protocols, vol. 21. Humana Press, Totowa, NJ, USA, pp. 309–339.
Harrach, B., Meehan, B.M., Benko¨, M., Adair, B.M., Todd, D., 1997. Close
phylogenetic relationship between egg drop syndrome virus, bovine
adenovirus serotype 7, and ovine adenovirus strain 287. Virology
229, 302–308.
Helin, K., Harlow, E., Fattaey, A., 1993. Inhibition of E2F-1 transactivation
by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13,
6501–6508.
Hofmann, C., Lo¨ser, P., Cichon, G., Arnold, W., Both, G.W., Strauss, M.,
1999. Ovine adenovirus vectors overcome preexisting humoral immun-
ity against human adenoviruses in vivo. J. Virol. 73, 6930–6936.
Huang, M.M., Hearing, P., 1989. The adenovirus early region 4 open read-
ing frame 6/7 protein regulates the DNA binding activity of the cellular
transcription factor, E2F, through a direct complex. Genes Dev. 3,
1699–1710.
Khatri, A., Both, G.W., 1998. Identification of transcripts and promoter
regions of ovine adenovirus OAV287. Virology 245, 128–141.
Khatri, A., Xu, Z.Z., Both, G.W., 1997. Gene expression by atypical re-
combinant ovine adenovirus vectors during abortive infection of human
and animal cells in vitro. Virology 239, 226–237.
Ku¨min, D., Hofmann, C., Rudolph, M., Both, G.W., Lo¨ser, P., 2002. Biol-
ogy of ovine adenovirus infection of nonpermissive cells. J. Virol. 76,
10882–10893.
Lehrmann, H., Cotten, M., 1999. Characterization of CELO virus proteins
that modulate the pRb/E2F pathway. J. Virol. 73, 6517–6525.
Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S., Weiss-
man, A.M., 1999. RING fingers mediate ubiquitin-conjugating en-
zyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. U. S. A.
96, 11364–11369.
Lo¨ser, P., Sandig, V., Kirillova, I., Strauss, M., 1996. Evaluation of HBV
promoters for use in hepatic gene therapy. Biol. Chem. Hoppe-Seyler
377, 187–193.
Lo¨ser, P., Cichon, G., Jennings, G.S., Both, G.W., Hofmann, C., 1999.
Ovine adenovirus vectors promote efficient gene delivery in vivo. Gene
Ther. Mol. Biol. 4, 33–43.
Lo¨ser, P., Hillgenberg, M., Arnold, W., Both, G.W., Hofmann, C., 2000.
Ovine adenovirus vectors mediate efficient gene transfer to skeletal
muscle. Gene Ther. 7, 1491–1498.
Lo¨ser, P., Ku¨min, D., Hillgenberg, M., Both, G.W., Hofmann, C., 2001.
Preparation of ovine adenovirus vectors. In: Morgan, J.R. (Ed.), 2nd ed.
Methods in Molecular Medicine, vol. 69. Humana Press, Totowa, NJ,
USA, pp. 415–426.
Lo¨ser, P., Hu¨ser, A., Hillgenberg, M., Ku¨min, D., Both, G.W., Hofmann,
C., 2002. Advances in the development of non-human viral DNA-vec-
tors for gene delivery. Curr. Gene Ther. 2, 161–171.
Lo¨ser, P., Hofmann, C., Both, G.W., Hillgenberg, M., 2003. Construction,
rescue and characterization of ovine atadenovirus vectors with im-
proved expession and stability. J. Virol. (in press).
Maizel Jr., J.V., White, D.O., Scharff, M.D., 1968. The polypeptides of
adenovirus. I. Evidence for multiple protein components in the virion
and a comparison of types 2, 7A, and 12. Virology 36, 115–125.
Marton, M.J., Baim, S.B., Ornelles, D.A., Shenk, T., 1990. The adenovirus
E4 17-kilodalton protein complexes with the cellular transcription factor
E2F, altering its DNA-binding properties and stimulating E1A-inde-
pendent accumulation of E2 mRNA. J. Virol. 64, 2345–2359.
Neill, S.D., Nevins, J.R., 1991. Genetic analysis of the adenovirus
E4 6/7 trans activator: interaction with E2F and induction of a
stable DNA–protein complex are critical for activity. J. Virol.
65, 5364–5373.
D. Ku¨min et al. / Virology 318 (2004) 79–89 89Neill, S.D., Hemstrom, C., Virtanen, A., Nevins, J.R., 1990. An adenovirus
E4 gene product trans-activates E2 transcription and stimulates stable
E2F binding through a direct association with E2F. Proc. Natl. Acad.
Sci. U. S. A. 87, 2008–2012.
Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H., Dobner, T., 2000. Two
distinct activities contribute to the oncogenic potential of the adenovirus
type 5 E4orf6 protein. J. Virol. 74, 5168–5181.
Nevins, J.R., 1995. Adenovirus E1A: transcription regulation and alteration
of cell growth control. Curr. Top. Microbiol. Immunol. 199, 25–32.
Obert, S., O’Connor, R.J., Schmid, S., Hearing, P., 1994. The adeno-
virus E4-6/7 protein transactivates the E2 promoter by inducing
dimerization of a heteromeric E2F complex. Mol. Cell. Biol. 14,
1333–1346.
O’Connor, R.J., Hearing, P., 1991. The C-terminal 70 amino acids of the
adenovirus E4-ORF6/7 protein are essential and sufficient for E2F com-
plex formation. Nucleic Acids Res. 19, 6579–6586.
Pye, D., 1989. Cell lines for growth of sheep viruses. Aust. Vet. J. 66,
231–232.
Reichel, R., Neill, S.D., Kovesdi, I., Simon, M.C., Raychaudhuri, P., Ne-
vins, J.R., 1989. The adenovirus E4 gene, in addition to the E1A gene,
is important for trans-activation of E2 transcription and for E2F activa-
tion. J. Virol. 63, 3643–3650.
Schaley, J., O’Connor, R.J., Taylor, L.J., Bar-Sagi, D., Hearing, P., 2000.
Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7
protein. J. Virol. 74, 2084–2093.
Shenk, T., 1996. Adenoviridae: the viruses and their replication. In: Fields,
B.N., Knipe, D.M., Howley, P.M. (Eds.), 3rd ed. Fields Virology, vol. 2.
Lippincott-Raven, Philadelphia, NY, pp. 2111–2148.
Ta¨uber, B., Dobner, T., 2001. Molecular regulation and biological function
of adenovirus early genes: the E4 ORFs. Gene 278, 1–23.Thomson, D., Meers, J., Harrach, B., 2002. Molecular confirmation of an
adenovirus in brushtail possums (Trichosurus vulpecula). Virus Res. 83,
189–195.
Venktesh, A., Watt, F., Xu, Z.Z., Both, G.W., 1998. Ovine adenovirus
(OAV287) lacks a virus-associated RNA gene. J. Gen. Virol. 79,
509–516.
Voeks, D., Martiniello-Wilks, R., Madden, V., Smith, K., Bennetts, E.,
Both, G.W., Russell, P.J., 2002. Gene therapy for prostate cancer
delivered by ovine adenovirus and mediated by purine nucleoside
phosphorylase and fludarabine in mouse models. Gene Ther. 9,
759–768.
Vrati, S., Boyle, D., Kocherhans, R., Both, G.W., 1995. Sequence of ovine
adenovirus homologs for 100K hexon assembly, 33K, pVIII, and fiber
genes: early region E3 is not in the expected location. Virology 209,
400–408.
Vrati, S., Brookes, D.E., Boyle, D.B., Both, G.W., 1996a. Nucleotide
sequence of ovine adenovirus tripartite leader sequence and homo-
logues of the IVa2, DNA polymerase and terminal proteins. Gene
177, 35–41.
Vrati, S., Brookes, D.E., Strike, P., Khatri, A., Boyle, D.B., Both, G.W.,
1996b. Unique genome arrangement of an ovine adenovirus: identifi-
cation of new proteins and proteinase cleavage sites. Virology 220,
186–199.
Xu, Z.Z., Hyatt, A., Boyle, D.B., Both, G.W., 1997. Construction of ovine
adenovirus recombinants by gene insertion or deletion of related termi-
nal region sequences. Virology 230, 62–71.
Xu, Z.Z., Nevels, M., MacAvoy, E.S., Lockett, L.J., Curiel, D., Dobner, T.,
Both, G.W., 2000. An ovine adenovirus vector lacks transforming abil-
ity in cells that are transformed by AD5 E1A/B sequences. Virology
270, 162–172.
